Market Cap
Novo Nordisk A/S
kr.2.120 Trillion
DKK as of Jan. 1, 2023
US$304.61 Billion
Company | Market Cap (USD) |
---|---|
![]() |
$93.24 B |
![]() |
$79.53 B |
Marinomed Biotech AG | $76.72 B |
![]() |
$74.13 B |
![]() |
$68.42 B |
Company | Market Cap (USD) |
---|---|
![]() |
$495.37 B |
![]() |
$461.85 B |
![]() |
$347.61 B |
![]() |
$287.63 B |
![]() |
$285.80 B |
Novo Nordisk A/S has the following listings and related stock indices.
Stock: OMXC: NOVO.B
Stock: Bovespa: N1VO34
Stock: NYSE: NVO
Stock: BMV: NVON
Stock: FSX: NOVC
Stock: XETR: NOVC
Stock: XETR: NOVA
Stock: FSX: NOVA
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.